Anu Mahajan
Research Subjects
Anu Mahajan has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Arti Muley
Symbiosis School of Culinary Arts and Nutritional Sciences, Symbiosis International (Deemed University), Pune, India
3 shared publications Jhanvee Shah
Department of Nutrition and Dietetics, Symbiosis School of Culinary Arts and Nutritional Sciences, Symbiosis International (Deemed University), Pune 412115, India
2 shared publications
Latest Publications
- Open Access
- 2 June 2026
- Published by SAGE Publications in Nutrition and Health
Feasibility and preliminary evaluation of a lacto-vegetarian diet combined with intermittent fasting in women with type 2 diabetes: A pilot randomized controlled trial
Background: Women living with type 2 diabetes mellitus (T2DM) often encounter unique physiological and lifestyle-related hurdles that impact disease progression and management. Dietary interventions tailored to cultural and gender-specific needs are essential for effective diabetes management. Aim: This pilot trial primarily evaluated feasibility and safety and, secondarily, explored the preliminary metabolic effects and practical implementation of a lacto-vegetarian diet combined with intermittent fasting in Indian women with T2DM. Methods: In this 12-week, parallel-group, open-label randomized controlled trial, 10 women with T2DM (aged 25–60 years) were randomly allocated in a 1:1 ratio using block randomization to either an intervention group (lacto-vegetarian diet within a 10-h eating window) or a control group (usual diet). Glycemic, lipid, and anthropometric parameters were measured at baseline and after the intervention. Safety, tolerability, and participant-reported experiences were also assessed. Results: Exploratory within-group analyses in the intervention arm demonstrated reductions in glycated hemoglobin (−11.3%), fasting insulin (−47.4%), body weight (−3.96.0%), and body mass index (−3.98%) while the control group showed no meaningful changes. Lipid parameters showed no meaningful changes. No serious adverse events occurred; mild fatigue, hypoglycemia, and constipation were reported but resolved without intervention. Participants expressed improvements in energy, appetite control, and emotional well-being. No reductions in diabetes medication were reported, likely due to the short duration of the intervention. Conclusion: This pilot randomized controlled trial was feasible, safe, and well-tolerated and showed signals of potential metabolic benefit in women with T2DM. This pilot study is part of an ongoing clinical trial, and the complete results will be presented upon completion of the full trial.
- 2 June 2026
- Published by SAGE Publications in Nutrition and Health
Open AccessFeasibility and preliminary evaluation of a lacto-vegetarian diet combined with intermittent fasting in women with type 2 diabetes: A pilot randomized controlled trial
Background: Women living with type 2 diabetes mellitus (T2DM) often encounter unique physiological and lifestyle-related hurdles that impact disease progression and management. Dietary interventions tailored to cultural and gender-specific needs are essential for effective diabetes management. Aim: This pilot trial primarily evaluated feasibility and safety and, secondarily, explored the preliminary metabolic effects and practical implementation of a lacto-vegetarian diet combined with intermittent fasting in Indian women with T2DM. Methods: In this 12-week, parallel-group, open-label randomized controlled trial, 10 women with T2DM (aged 25–60 years) were randomly allocated in a 1:1 ratio using block randomization to either an intervention group (lacto-vegetarian diet within a 10-h eating window) or a control group (usual diet). Glycemic, lipid, and anthropometric parameters were measured at baseline and after the intervention. Safety, tolerability, and participant-reported experiences were also assessed. Results: Exploratory within-group analyses in the intervention arm demonstrated reductions in glycated hemoglobin (−11.3%), fasting insulin (−47.4%), body weight (−3.96.0%), and body mass index (−3.98%) while the control group showed no meaningful changes. Lipid parameters showed no meaningful changes. No serious adverse events occurred; mild fatigue, hypoglycemia, and constipation were reported but resolved without intervention. Participants expressed improvements in energy, appetite control, and emotional well-being. No reductions in diabetes medication were reported, likely due to the short duration of the intervention. Conclusion: This pilot randomized controlled trial was feasible, safe, and well-tolerated and showed signals of potential metabolic benefit in women with T2DM. This pilot study is part of an ongoing clinical trial, and the complete results will be presented upon completion of the full trial.
- Open Access
- 30 April 2026
- Published by Wolters Kluwer Health in Precision Nutrition
- Vol. 5 (2) , e00136
Breathe away diabetes: a review of the epigenetic impact of pranayama on diabetes management and prevention
Background: To critically evaluate the biological and epigenetic pathways through which pranayama may influence metabolic regulation relevant to the prevention and management of type 2 diabetes mellitus. This review also synthesizes mechanistic findings across oxidative stress pathways, mitochondrial bioenergetics, inflammatory signaling, cortisol dynamics, and autonomic regulation to analyze how breath-based interventions may modulate diabetes-related molecular and physiological processes. Methods: Databases were searched for the decade 2014–2024 using the Keywords “Pranayama,” or “Pranayama therapy,” and “Oxidative stress,” and “Mitochondrial function,” and “cortisol,” and “Autonomic nervous system,” in combination with “Type 2 Diabetes” or “Diabetes Mellitus.” The review aimed to provide a comprehensive discussion of the current topic and, thus, does not include any specific data synthesis. Results: Current literature demonstrates that pranayama modulates several biological pathways implicated in both the development and management of type 2 diabetes. Studies report reductions in reactive oxygen species (ROS) and improvements in total antioxidant capacity (TAC), indicating enhanced regulation of oxidative stress. Improved NAD + levels and COX-II activity suggest a positive influence on mitochondrial function. Additionally, pranayama has been shown to lower cortisol levels and C-reactive protein (CRP) while improving autonomic balance, all of which are associated with improved insulin sensitivity and glycemic control. Conclusions: By mitigating oxidative stress, enhancing mitochondrial efficiency, modulating inflammation, lowering stress-related cortisol secretion, and improving autonomic nervous system tone, pranayama may support both the prevention and management of type 2 diabetes. Future randomized controlled trials are warranted to further validate these mechanisms and clinical outcomes.
- 30 April 2026
- Published by Wolters Kluwer Health in Precision Nutrition
- Vol. 5 (2) , e00136
Open AccessBreathe away diabetes: a review of the epigenetic impact of pranayama on diabetes management and prevention
Background: To critically evaluate the biological and epigenetic pathways through which pranayama may influence metabolic regulation relevant to the prevention and management of type 2 diabetes mellitus. This review also synthesizes mechanistic findings across oxidative stress pathways, mitochondrial bioenergetics, inflammatory signaling, cortisol dynamics, and autonomic regulation to analyze how breath-based interventions may modulate diabetes-related molecular and physiological processes. Methods: Databases were searched for the decade 2014–2024 using the Keywords “Pranayama,” or “Pranayama therapy,” and “Oxidative stress,” and “Mitochondrial function,” and “cortisol,” and “Autonomic nervous system,” in combination with “Type 2 Diabetes” or “Diabetes Mellitus.” The review aimed to provide a comprehensive discussion of the current topic and, thus, does not include any specific data synthesis. Results: Current literature demonstrates that pranayama modulates several biological pathways implicated in both the development and management of type 2 diabetes. Studies report reductions in reactive oxygen species (ROS) and improvements in total antioxidant capacity (TAC), indicating enhanced regulation of oxidative stress. Improved NAD + levels and COX-II activity suggest a positive influence on mitochondrial function. Additionally, pranayama has been shown to lower cortisol levels and C-reactive protein (CRP) while improving autonomic balance, all of which are associated with improved insulin sensitivity and glycemic control. Conclusions: By mitigating oxidative stress, enhancing mitochondrial efficiency, modulating inflammation, lowering stress-related cortisol secretion, and improving autonomic nervous system tone, pranayama may support both the prevention and management of type 2 diabetes. Future randomized controlled trials are warranted to further validate these mechanisms and clinical outcomes.
- Open Access
Yoga practice duration and its influence on type 2 diabetes management: A meta-analysis of Asian population